With 24 Cell & Gene Therapy related patents published between 2002 and 2022, Straumann Holding AG holds the most number of Cell & Gene Therapy patents in the global Construction sector.
The second largest number of Cell & Gene Therapy related patents were published by SINTX Technologies Inc with 13 patents. The third largest number of Cell & Gene Therapy related patents were published by University of Technology Sydney with 8 patents. The fourth largest number of Cell & Gene Therapy related patents were published by OssDsign AB with 8 patents. The fifth largest number of Cell & Gene Therapy related patents were published by Ceram Gmbh with 6 patents.
The top five patent holders, i.e., Straumann Holding AG, SINTX Technologies Inc, University of Technology Sydney, OssDsign AB, and Ceram Gmbh, together held 59 Cell & Gene Therapy patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer